Brandywine Global Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Brandywine Global Investment Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-116,763	Closed	-$4.73M	–	851
2019 Q4	$4.73M	Sell	116,763 -3,762	-3%	-$140K	0.03%	413
2019 Q3	$4.18M	Sell	120,525 -39,340	-25%	-$1.3M	0.03%	422
2019 Q2	$5.07M	Buy	159,865 +42,175	+36%	+$1.25M	0.04%	409
2019 Q1	$3.52M	Buy	+117,690	New	+$3.37M	0.02%	448

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Brandywine Global Investment Management's PBH Position: Q1 2020 in Review

Brandywine Global Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2020, closing a stake of 116,763 shares — an estimated $4.73M sold.

Brandywine Global Investment Management first reported a position in PBH in Q1 2019 and held it in 4 quarters. The position peaked at $5.07M in Q2 2019. 250 funds tracked by Wall St. Rank hold PBH as of Q1 2020.

Brandywine Global Investment Management reported no remaining Prestige Consumer Healthcare position as of Q1 2020 after selling out during the quarter.
Brandywine Global Investment Management sold 116,763 Prestige Consumer Healthcare shares in Q1 2020, an estimated $4.73M.
Brandywine Global Investment Management first reported a position in Prestige Consumer Healthcare in Q1 2019 and held it in 4 quarters.
Brandywine Global Investment Management's Prestige Consumer Healthcare position peaked at $5.07M in Q2 2019.
250 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2020.

Based on Brandywine Global Investment Management's 13F filing for Q1 2020, filed 15 May 2020.